Cargando…
Targeting AraC-Resistant Acute Myeloid Leukemia by Dual Inhibition of CDK9 and Bcl-2: A Systematic Review and Meta-Analysis
PURPOSE: This study aims to determine the influence of targeting araC-resistant acute myeloid leukemia by dual inhibition cyclin-dependent protein kinase (CDK9) and B-cell lymphoma-2 (Bcl-2). METHOD: The c-Myc inhibitor 10058-F4 and the CDK9 inhibitor AZD4573 were used to determine the cell cycle ar...
Autores principales: | Li, Linzhang, Han, Chengwu, Yu, Xueying, Shen, Jun, Cao, Yongtong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808115/ https://www.ncbi.nlm.nih.gov/pubmed/35126914 http://dx.doi.org/10.1155/2022/2842066 |
Ejemplares similares
-
Retracted: Targeting AraC-Resistant Acute Myeloid Leukemia by Dual Inhibition of CDK9 and Bcl-2: A Systematic Review and Meta-Analysis
por: Healthcare Engineering, Journal of
Publicado: (2023) -
DNA tape measurements of AraC
por: Rodgers, Michael E., et al.
Publicado: (2008) -
AraC-Based Biosensor
for the Detection of Isoprene
in E. coli
por: Bhat, Shrilaxmi, et al.
Publicado: (2023) -
Liposomally trapped AraCTP to overcome AraC resistance in a murine lymphoma in vitro.
por: Richardson, V. J., et al.
Publicado: (1982) -
Blockade of CD82 by a monoclonal antibody potentiates anti-leukemia effects of AraC in vivo
por: Nishioka, Chie, et al.
Publicado: (2015)